Meeting to be held in Denver on November 14 hosted by Jefferies.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on HOWL:
- Werewolf Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
- Werewolf Therapeutics price target raised to $15 from $12 at Jefferies
- Werewolf present preliminary data from Phase 1/1b trial for WTX-124
- Werewolf Therapeutics Presents Preliminary Monotherapy Data from Phase 1/1b Clinical Trial Establishing Proof of Mechanism for WTX-124 at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meeting
- Werewolf abstract shows positive signals for WTX-124, says H.C. Wainwright